Search Within

Brian Kushner

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (16)
  3. Conference Paper (2)
  4. Book Section (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (38)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (38)
  3. GSK Faculty (38)
  4. Molecular Imaging and Therapy Service (38)
  5. Neuroblastoma Service (38)
  6. Pediatrics, Department of (38)

More Groups

People
  1. Nai-Kong Cheung (38)
  2. Steven Larson (31)
  3. Kim Kramer (28)
  4. Shakeel Modak (25)
  5. Neeta Pandit-Taskar (22)
  6. Pat Zanzonico (16)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2020 (1)
  5. 2019 (3)
  6. 2018 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (11)
  2. Journal of Clinical Oncology (6)
  3. Neuro-Oncology (6)
  4. Journal of Nuclear Medicine (2)
  5. Medical and Pediatric Oncology (2)
  6. Progress in Clinical and Biological Research (2)

More Publications

Publishers
  1. Wiley Periodicals, Inc (11)
  2. American Society of Clinical Oncology (6)
  3. Oxford University Press (6)
  4. American Association for Cancer Research (2)
  5. John Wiley & Sons, Inc. (2)
  6. Society of Nuclear Medicine (2)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MRI compared to (123)I-MIBG scan for detection of central nervous system relapse in neuroblastoma
    Meeting Abstract

    Stiefel, J.; Kramer, K.; Haque, S.; Basu, E. M.; Kushner, B. H.; Pandit-Taskar, N.; Katz, A.; Cheung, N. K. V.; Modak, S.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Case study #2: Disialoganglioside GD2 as a target for radiopharmaceutical therapy
    Book Section

    Cheung, N. K. V.; Kramer, K.; Modak, S.; Kushner, B. H.; Ahmed, M.; Santich, B.; Cheal, S.; Larson, S.
    In Bodei, L.; Lewis, J. S.; Zeglis, B. M. (Eds.) Radiopharmaceutical Therapy (2023)

    Fulltext@MSK | Save
  • Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Casey, D. L.; Kushner, B. H.; Luo, L.; Pandit-Taskar, N.; Souweidane, M.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Meeting Abstract

    Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save